CD25 Antibody, anti-human, APC 130-113-280 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD25 Antibody, anti-human, APC

The CD25 Antibody, anti-human, APC from Miltenyi Biotec is a Mouse Monoclonal antibody to IL2RA. This antibody recognizes Human, and Non-Human Primate antigen. The CD25 Antibody, anti-human, APC has been validated for the following applications: Staining, Fluorescence, Microscopy, Flow Cytometry, Immunofluorescence, and Immunohistochemistry.

Product Specs
ItemCD25 Antibody, anti-human, APC
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-113-280
Quantity100 tests in 200 µL
ApplicationsFlow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
Conjugate/TagAPC
Reactivityhuman, non-human primate
IsotypeIgG2b
Clone4E3
Hostmouse
Antibody TypePrimary antibodies
NCBI Full Gene Nameinterleukin 2 receptor subunit alpha
NCBI Gene AliasesCD25, IDDM10, IL2R, IMD41, TCGFR, p55
Clonalitymonoclonal
Concentration1:50
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
TargetCD25
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Cell-Based Models of ''Cytokine Release Syndrome'' Endorse CD40L and Granulocyte-Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation StrategyCellsNovember 6, 2023Dibas A, Rhiel M, Patel VB, Andrieux G, Boerries M, Cornu TI, Alzubi J, Cathomen T.(clone 4E3, Miltenyi Biotec, cat# 130-113-282), anti-human CD25-APC (clone 4E3, Miltenyi Biotec, cat# 130-113-280), anti-human CD69-PE (clone FN50, BD, Heidelberg, Germany, cat# 555531), anti-human CD40-PE (clone 17,

(2) Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR⁺ NK cell levels correlate with disease outcomeOncoimmunologyFebruary 1, 2013Chaput N, Flament C, Locher C, Desbois M, Rey A, Rusakiewicz S, Poirier-Colame V, Pautier P, Le Cesne A, Soria JC, et al.

(3) Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alphaBloodOctober 15, 2008Lamprecht B, Kreher S, Anagnostopoulos I, Jöhrens K, Monteleone G, Jundt F, Stein H, Janz M, Dörken B, Mathas S.

(4) Regulatory T cells in the control of immune pathologyNature immunologySeptember 1, 2001Maloy KJ, Powrie F.

(5) Certified professionals: CD4(+)CD25(+) suppressor T cellsThe Journal of experimental medicineJune 4, 2001Shevach EM.

(6) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseasesJournal of immunology (Baltimore, Md. : 1950)August 1, 1995Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M.

Be the First to Write a Review!